Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008
Trapped in Bed (After 32 Years of a Blocked Nose)
Lancet 372:1606, Imtiaz,K.E.,et al, 2008
Mitoxantrone as Induction Treatment in aggressive Relapsing Remitting Multiple Sclerosis: Treatment Response Factors in a 5 Year Follow-up Observational Study of 100 Consecutive Patients
JNNP 79:52-56, Le Page,E.,et al, 2008
B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008
Diagnosis and Management of Motor Neurone Disease
BMJ 336:658-662, McDermott,C.J. &Shaw,P.J., 2008
Recurrent Guillain-Barr� Syndrome
JNNP 80:56-59, Kuitwaard,K.,et al, 2008
Bal�s Disease Showing Benign Clinical Course and Co-Existence with Multiple Sclerosis-Like Lesions in Chinese
Multiple Sclerosis 14:418-424, Wang,C.,et al, 2008
Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
Arch Neuol 65:1313-1318, Claassen,D.O.,et al, 2008
Racial Differences in Microbleed Prevalence in Primary Intracerebral Hemorrhage
Neurol 71:1176-1182, Copenhaver,B.R.,et al, 2008
Intraventricular Hemorrhage: Anatomic Relationships and Clinical Implications
Neurol 70:848-852, Hallevi,H.,et al, 2008
Guillain-Barr\� Syndrome: Incidence and Mortality Rates in US Hospitals
Neurol 70:16081-1613, Alshekhlee,A.,et al, 2008
Effect of Laquinimod on MRI-Monitored Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIb Study
Lancet 371:2085-2092,2059, Comi,G.,etc., 2008
Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008
Guillain-Barre Syndrome
BMJ 337:227-231, Winer,J.B., 2008
Large Artery Intracranial Occlusive Disease: A Large Worldwide Burden But a Relatively Neglected Frontier
Stroke 39:2396-2399, Gorelick,P.B.,et al., 2008
Transient Global Amnesia: Diffusion-Weighted Imaging Lesions and Cerebrovascular Disease
Stroke 39:2219-2225, Enzinger,C.,et al., 2008
Juvenile Dermatomyositis and Other Idiopathic Inflammatory Myopathies of Childhood
Lancet 371:2201-2212, Feldman,B.M.,et al., 2008
Stroke Location and Association With Fatal Cardiac Outcomes: Northern Manhattan Study (NOMAS)
Stroke 39:2425-2431, Rincon,F.,et al., 2008
Stroke Syndrome Secondary to Hypercoagulability of Lung Cancer
Commun Oncol 5:595-596, Lim, B. & Henry, D.H., 2008
Ethylene Glycol Toxicity: Chemistry, Pathogenesis, and Imaging
Radiology Case Reports 3, Moore, M.M.,et al, 2008
Differential Diagnosis of Restricted Diffusion Confined to the Cerebral Cortex
Clin Radiol 63:1245-1253, Sheerin,F.,et al, 2008
Optimal Diffusion-Weighted Imaging Protocol for Lesion Detection in Transient Global Amnesia
AJNR 29:1324-1328, Weon, Y.C.,et al, 2008
Warfarin-associated intraventricular hemorrhage
Neurol Res 29: 661-663, Zubkov, A.,et al, 2007
HIV Infection Presenting with Motor Axonal Variant of Guillain-Barre Syndrome
J Clin Neuromusc Dis 9:303-305, Wagner, J.C. and Bromberg, M.B., 2007
Stroke as the First Manifestation of Concealed Cancer
J Neurol Sci 258:80-83, Kwon, H.M.,et al, 2007
Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007
Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007
Patterns of Guillain-Barre Syndrome in Children: Results From a Mexican Population
Neurol 69:1665-1671,1647, Nachamkin,I.,et al, 2007
How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007
Continuous Spectrum of Pharyngeal-Cervical-Brachial Variant of Guillain-Barr� Syndrome
Arch Neurol 64:1519-1523, Nagashima,T.,et al, 2007
Neuroblastoma
Lancet 369:2106-2120, Maris,J.M.,et al, 2007
Pattern of Cortical Changes in Sporadic Creutzfeldt-Jakob Disease
AJNR 28:1114-1118, Tschampa,H.J.,et al, 2007
Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007
Neurological Findings in Aminoacylase 1 Deficiency
Neurol 68:2151-2153, Sass,J.O.,et al, 2007
Systematic Comparison of Perfusion-CT and CT-Angiography in Acute Stroke Patients
Ann Neurol 61:533-543,501, Tan,J.C.,et al, 2007
Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007
Effect of Early Verus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-Year Follow-Up Analysis of the BENEFIT Study
Lancet 370:389-397, Kappos,L.,et al, 2007
Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007
Patterns of Sensory Abnormality in Cortical Stroke: Evidence for a Dichotomized Sensory System
Neurol 68:174-180, Kim,J.S., 2007
Bilateral Ocular Paralysis: Analysis of 31 Inpatients
Arch Neurol 64:178-180, Keane,J.R., 2007
Longitudinal Follow-Up of "Benign" Multiple Sclerosis at 20 Years
Neurol 68:496-500,480, Sayao,A-L.,et al, 2007
Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS
Neurol 68:939-944, Cohen,J.A.,et a, 2007
Utility of Urinalysis in Discriminating Cardioembolic Stroke Mechanism
Arch Neurol 64:667-670, Viehman,J.A.,et al, 2007
Collapse, Reported Seizure--And An Unexpected Pill
Lancet 369:1490, Wood,D.M.,et al, 2007
Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007
MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007
Digital Map of Posterior Cerebral Artery Infarcts Associated With Posterior Cerebral Artery Trunk and Branch Occlusion
Stroke 38:1805-1811, Phan,T.G.,et al, 2007
Posterior Reversible Encephalopathy and Guillain-Barre Syndrome in a Single Patient: Coincidence or Causative Relation?
Clin Neurol Neurosurg 109:58-62, Van Diest,D.,et al, 2007
Pediatric Encephalitis: What Is the Role of Mycoplasma Pneumoniae
Pediatrics 120:305-313, Christie,L.J., et al, 2007